At Catamaran, our mission is to harness the power of our proprietary TAILWIND™ Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.
| Website | https://www.catamaranbio.com/ |
| Employees | 11 (11 on RocketReach) |
| Founded | 2020 |
| Address | 451 D St Fl 5, Boston, Massachusetts 02210, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Drug Discovery |
| Keywords | Immune Cell Therapy, Off The Shelf Therapy, Cancer Treatment, Cancer Immunotherapy, Oncology Therapeutics, Immunotherapy, Clinical Stage Biopharmaceutical, Therapeutic Platform, Precision Medicine, Personalized Medicine, Regenerative Medicine, Biotechnology, Pharmaceutical Development, Drug Development, Biologics, Immune System |
| Competitors | Amgen, Novartis, Gilead Sciences, AbbVie, Vertex Pharmaceuticals, Genentech, Sanofi, Biogen, Regeneron, Lilly India +46 more (view full list) |
Looking for a particular Catamaran Bio employee's phone or email?
Eugene Choi is the Associate Director, In Vitro Pharmacology of Catamaran Bio.
11 people are employed at Catamaran Bio.
Catamaran Bio is based in Boston, Massachusetts.